Boardroom Alpha
Boardroom Alpha
ELMD · Current Report (Form 8-K) · Filed December 18, 2025

Electromed Inc — Current Report (Form 8-K)

Form
8-K
Filed
December 18, 2025
Period
Dec 16, 2025
Ticker
ELMD
Accession
0001437749-25-038291
Boardroom Alpha · Filing insights

Electromed secures a $10M revolver with BMO, maturing Dec 16, 2026, secured by assets (replacing prior facility).

About Electromed Inc
Market cap
$237M
1Y TSR
+12.1%
3Y TSR
+37.7%
Board grade
A
Sector
Healthcare
CEO
James L Cunniff
Last annual meeting: Nov 13, 2026 · View full Electromed Inc profile →
elmd20251209_8k.htm
DMS_US.374923169.2
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 
     
 
FORM 8-K 
     
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
Date of report (Date of earliest event reported): December 16, 2025
     
 
ELECTROMED, INC.
(Exact Name of Registrant as Specified in Its Charter)
 
Minnesota
001-34839
41-1732920
(State or Other Jurisdiction of
Incorporation)
(Commission File Number)
(I.R.S. Employer Identification
Number)
 
500 Sixth Avenue NW
New Prague, MN 56071
(Address of Principal Executive Offices) (Zip Code)
 
(952) 758-9299
(Registrant’s Telephone Number, Including Area Code)
 
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
     
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
Securities registered pursuant to Section 12(b) of the Act:
 
Common Stock, $0.01 par value
 
ELMD
 
NYSE American LLC
(Title of each class)
 
(Trading Symbol)
 
(Name of each exchange on which registered)
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.
Emerging growth company ☐
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
 
Item 1.01
Entry into a Material Definitive Agreement.
 
On December 16, 2025, Electromed, Inc. (the “Company”) entered a Credit Agreement (the “Credit Agreement”) with BMO Bank N.A. (“Lender”), as lender. The Credit Agreement provides the Company with a senior security credit facility with a $10,000,000 revolving line of credit (the “Credit Facility”). The Credit Agreement provides that the Credit Facility will mature on December 16, 2026. Any borrowings under the Credit Facility will bear interest at one-month Term SOFR plus 1.75%, payable monthly.
 
The Company provided a first priority security interest in substantially all of its existing and future assets to secure the payment obligations under the Credit Agreement. The Credit Agreement contains certain customary covenants that limit the Company’s ability to engage in certain transactions. The Credit Agreement also contains customary indemnification obligations and events of default, including, among other things, (i) non-payment, (ii) non-performance of covenants and obligations, (iii) default on other indebtedness, (iv) judgments, (v) misrepresentation and (vi) bankruptcy and insolvency. The Company may use the proceeds of the Credit Facility to finance capital expenditures and for working capital and general corporate purposes.
 
In addition, at any time that there is any borrowing under the Credit Facility, the Company is subject to certain financial covenants, including maintaining a minimum Fixed Charge Coverage Ratio of at least 1.20x and a Total Funded Debt to EBITDA (as each such term is defined in the Credit Agreement) ratio of not more than 2.50x, each calculated on a quarterly basis over a rolling four-quarter period.
 
The foregoing description of the Credit Facility is qualified by reference to the text of the Credit Agreement, a copy of which is attached as Exhibits 10.1 and incorporated herein by reference. 
 
Item 2.03
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.
 
In connection with the execution of the Credit Facility described in response to Item 1.01 of this Current Report on Form 8-K, the Company terminated its existing credit facility with Choice Financial Group.
 
Item 9.01
Financial Statements and Exhibits.
 
 
(d) Exhibits:
 
Exhibit Number
 
Description
 
104
 
Cover Page Interactive Data File (embedded in the cover page and formatted in inline XBRL)
*Certain exhibits have been omitted pursuant to Item 601(a)(5) of Regulation S-K. A copy of any omitted exhibit can be furnished to the SEC upon request.
 
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
ELECTROMED, INC.
     
Date: December 18, 2025
By:
/s/ Bradley M. Nagel
 
Name:
Bradley M. Nagel
 
Title:
Chief Financial Officer
 
 
 
 
From this filing to the file

Every SEC filing, parsed structured.

Boardroom Alpha indexes every 8-K, 10-K, 10-Q, and proxy back to 2000 — vote tabulations, comp tables, red flags, insider transactions, all queryable the day they hit EDGAR.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Electromed Inc (ELMD)

Reference

Frequently asked questions

When did Electromed Inc file this 8-K?
Electromed Inc (ELMD) filed this Current Report (Form 8-K) with the SEC on December 18, 2025. The accession number assigned by EDGAR is 0001437749-25-038291.
What does an 8-K disclose?
Form 8-K is the SEC's current-report form, used to disclose material events between periodic reports (10-K / 10-Q). Triggers include CEO/CFO departures, acquisitions, bankruptcies, earnings releases, auditor changes, changes in fiscal year, and amendments to corporate governance. Each 8-K is keyed to one or more Item numbers (1.01 through 9.01).
What is the key takeaway from this filing?
Electromed secures a $10M revolver with BMO, maturing Dec 16, 2026, secured by assets (replacing prior facility). This is Boardroom Alpha's one-line summary of the current report; see the full filing text above for the formal disclosure.
What Item codes does an 8-K cover?
An 8-K's Item codes (1.01 through 9.01) specify what kind of event is being disclosed — e.g. Item 1.01 for entering a material agreement, Item 5.02 for departure/election of directors and executive officers, Item 8.01 for other events. The Item codes for this 8-K appear in the filing text above.
Where can I find Electromed Inc's prior current reports on EDGAR?
The SEC EDGAR browser lists every 8-K Electromed Inc has filed under CIK 1488917, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer